Latest Product News
OXGENE Introduces TESSA Technology for Robust and Reproducible AAV Manufacture at Scale
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture at scale. These include high cost of goods, and low packaging efficiency. TESSA aims to deliver a paradigm shift in scalable AAV manufacture.
ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents to commercialize CRISPR gene editing.
PCR Biosystems Launches RiboShield™ RNase Inhibitor
PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.
Genomic Leaders To Create Australia’s First National COVID-19 Tracking System
Illumina announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using genomics across the country, rather than state by state, under a ground-breaking initiative spearheaded by Australia’s public health laboratory organisations and leading industry partners.
Promega and Hitachi High-Tech Launch Spectrum Compact CE Benchtop DNA Analysis Instrument
Promega has launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech.
Daicel Arbor Launches Improved myBaits Protocol
Daicel Arbor has announced an advance in the latest myBaits kit reagent chemistry and associated protocol referred to as myBaits Version 5.
Thermo Fisher Introduces Hematology-Oncology Portfolio for Rapid NGS Results
Thermo Fisher Scientific has announced a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System designed to enable a future in which turnaround times for next-generation sequencing results can be reduced to less than 24 hours.
Horizon Discovery Introduces Single Cell RNAseq-Linked CRISPR Screening Service
Horizon Discovery Group plc has announced the addition of single cell RNAseq-linked pooled CRISPR screening to its CRISPR screening services portfolio.
Agilent, Merck and Danaher Invest $89 Million in Benchtop DNA Printer Technology
DNA Script has announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million, with investors including Agilent, Merck and Danaher.
Thermo Fisher Expands GlobalAccess Sequencing Program to Oncology Labs
The company has extended program benefits to oncology laboratories and fast-tracking access to comprehensive molecular profiling on the Genexus System.